Review



mrsa blood isolates  (Anhui Medical University)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Anhui Medical University mrsa blood isolates
    Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against <t>mrsa</t> in Static-concentration time- kill studies. Different dose, <t>(A)</t> <t>43300</t> 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.
    Mrsa Blood Isolates, supplied by Anhui Medical University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+blood+isolates/mrsa+blood+isolates/pmc11955620-39-4-28
    Average 90 stars, based on 1 article reviews
    mrsa blood isolates - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus"

    Article Title: Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus

    Journal: Frontiers in Microbiology

    doi: 10.3389/fmicb.2025.1511707

    Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against mrsa in Static-concentration time- kill studies. Different dose, (A) 43300 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.
    Figure Legend Snippet: Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against mrsa in Static-concentration time- kill studies. Different dose, (A) 43300 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.

    Techniques Used: Activity Assay, Concentration Assay, Control

    Simultaneous or sequential administration of fosfomycin and linezolid against mrsa with time-kill curves in a dynamic PK/PD model. (A) 43300; (B) Isolate 1; (C) Isolate 2; (D) Isolate 3. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time. Control: no drug; 0 h concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.
    Figure Legend Snippet: Simultaneous or sequential administration of fosfomycin and linezolid against mrsa with time-kill curves in a dynamic PK/PD model. (A) 43300; (B) Isolate 1; (C) Isolate 2; (D) Isolate 3. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time. Control: no drug; 0 h concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.

    Techniques Used: Control

    Related Articles

    Activity Assay:

    Article Title: Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus
    Article Snippet: A total of three MRSA blood isolates and the methicillin-resistant Staphylococcus aureus strain ATCC 43300 were obtained from the Bacterial Resistance Centre of the First Affiliated Hospital of Anhui Medical University.

    Concentration Assay:

    Article Title: Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus
    Article Snippet: A total of three MRSA blood isolates and the methicillin-resistant Staphylococcus aureus strain ATCC 43300 were obtained from the Bacterial Resistance Centre of the First Affiliated Hospital of Anhui Medical University.

    Control:

    Article Title: Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus
    Article Snippet: A total of three MRSA blood isolates and the methicillin-resistant Staphylococcus aureus strain ATCC 43300 were obtained from the Bacterial Resistance Centre of the First Affiliated Hospital of Anhui Medical University.



    Similar Products

    mrsa 2 blood stream isolates  (Kamada)
    90
    Kamada mrsa 2 blood stream isolates
    Mrsa 2 Blood Stream Isolates, supplied by Kamada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+blood+isolates/mrsa+2+blood+stream+isolates/pm40449587-232-13-4
    Average 90 stars, based on 1 article reviews
    mrsa 2 blood stream isolates - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    mrsa blood isolates  (Anhui Medical University)
    90
    Anhui Medical University mrsa blood isolates
    Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against <t>mrsa</t> in Static-concentration time- kill studies. Different dose, <t>(A)</t> <t>43300</t> 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.
    Mrsa Blood Isolates, supplied by Anhui Medical University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+blood+isolates/mrsa+blood+isolates/pmc11955620-39-4-28
    Average 90 stars, based on 1 article reviews
    mrsa blood isolates - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    wgs on mrsa blood culture isolates  (Illumina Inc)
    90
    Illumina Inc wgs on mrsa blood culture isolates
    Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against <t>mrsa</t> in Static-concentration time- kill studies. Different dose, <t>(A)</t> <t>43300</t> 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.
    Wgs On Mrsa Blood Culture Isolates, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mrsa+blood+isolates/wgs+on+mrsa+blood+culture+isolates/pm32016400-31-47-55
    Average 90 stars, based on 1 article reviews
    wgs on mrsa blood culture isolates - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against mrsa in Static-concentration time- kill studies. Different dose, (A) 43300 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.

    Journal: Frontiers in Microbiology

    Article Title: Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus

    doi: 10.3389/fmicb.2025.1511707

    Figure Lengend Snippet: Bactericidal activity of fosfomycin and linezolid administered simultaneously or sequentially against mrsa in Static-concentration time- kill studies. Different dose, (A) 43300 1 × mic fos + 0.5 × mic lzd (B) 43300 0.5 × mic fos + 1 × mic lzd (C) 43300 1 0.5 × mic fos + 0.5 × mic lzd (D) Isolate 1 1 1 × mic fos + 0.5 × mic lzd (E) Isolate 1 0.5 × mic fos + 1 × mic lzd (F) Isolate 1 0.5 × mic fos + 0.5 × mic lzd (G) Isolate 2 1 × mic fos + 0.5 × mic lzd (H) Isolate 2 0.5 × mic fos + 1 × mic lzd (I) Isolate 2 0.5 × mic fos + 0.5 × mic lzd (J) Isolate 3 1 × mic fos + 0.5 × mic lzd (K) Isolate 3 0.5 × mic fos + 1 × mic lzd (L) Isolate 3 0.5 × mic fos + 0.5 × mic lzd. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.

    Article Snippet: A total of three MRSA blood isolates and the methicillin-resistant Staphylococcus aureus strain ATCC 43300 were obtained from the Bacterial Resistance Centre of the First Affiliated Hospital of Anhui Medical University.

    Techniques: Activity Assay, Concentration Assay, Control

    Simultaneous or sequential administration of fosfomycin and linezolid against mrsa with time-kill curves in a dynamic PK/PD model. (A) 43300; (B) Isolate 1; (C) Isolate 2; (D) Isolate 3. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time. Control: no drug; 0 h concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.

    Journal: Frontiers in Microbiology

    Article Title: Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus

    doi: 10.3389/fmicb.2025.1511707

    Figure Lengend Snippet: Simultaneous or sequential administration of fosfomycin and linezolid against mrsa with time-kill curves in a dynamic PK/PD model. (A) 43300; (B) Isolate 1; (C) Isolate 2; (D) Isolate 3. Control: no drug; 0 h, concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time. Control: no drug; 0 h concurrent administration group; 2 h, 4 h, 6 h, 8 h, sequential administration group, interval time.

    Article Snippet: A total of three MRSA blood isolates and the methicillin-resistant Staphylococcus aureus strain ATCC 43300 were obtained from the Bacterial Resistance Centre of the First Affiliated Hospital of Anhui Medical University.

    Techniques: Control